1. Home
  2. NNY vs RNAC Comparison

NNY vs RNAC Comparison

Compare NNY & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Municipal Value Fund

NNY

Nuveen New York Municipal Value Fund

HOLD

Current Price

$8.70

Market Cap

161.7M

Sector

Finance

ML Signal

HOLD

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$7.23

Market Cap

175.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNY
RNAC
Founded
1987
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
175.8M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
NNY
RNAC
Price
$8.70
$7.23
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$38.80
AVG Volume (30 Days)
50.9K
191.8K
Earning Date
01-01-0001
03-12-2026
Dividend Yield
4.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,091,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.58
$5.98
52 Week High
$8.87
$20.12

Technical Indicators

Market Signals
Indicator
NNY
RNAC
Relative Strength Index (RSI) 61.10 47.70
Support Level $8.60 $7.18
Resistance Level $8.75 $7.63
Average True Range (ATR) 0.13 0.55
MACD 0.00 0.03
Stochastic Oscillator 63.89 42.78

Price Performance

Historical Comparison
NNY
RNAC

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.

Share on Social Networks: